<DOC>
	<DOCNO>NCT00378677</DOCNO>
	<brief_summary>The purpose study investigate whether dry powder inhalation Cyclosporine A beneficial lung transplant patient Bronchiolitis Obliterans Syndrome . For patient suffer syndrome often therapeutic option available . Furthermore , side effect maintenance therapy leave room dose increment . The hypothesis trial Cyclosporine A administer locally ( lung ) chronic rejection treat effectively without extra systemic side effect .</brief_summary>
	<brief_title>Dry Powder Inhalation Cyclosporine A Lung Transplant Patients With Bronchiolitis Obliterans Syndrome</brief_title>
	<detailed_description>Because calcineurin inhibitor completely effective full prevention acute rejection correspond chronic disfunction transplant organ ( Bronchiolitis Obliterans Syndrome , BOS ) rejection risc remain . To effectively treat BOS high dos calcineurin inhibitor necessary . On hand high dos lead te serious side effect . The search balance effectiveness side effect lead dose adjustment . Ultimately , chronic rejection unstoppable . In order treat chronic rejection high dos calcineurin inhibitor therapeutic option . The option reach high dose target organ without extra systemic side effect would inhalation . Indeed , extensively investigated University Pittsburgh ( lead investigator Iacono ) . The intervention Pittsburgh trial exist nebulization Cyclosporine propylene glycol pretreatment nebulization lidocaine/albuterol order make inhalation tolerable . The investigational drug trial consist dry powder inhalation sugar-glass base solid dispersion contain cyclosporine A . The effectiveness measure compare Forced Expiratory Volume 1 second ( FEV1 ) intervention .</detailed_description>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Bronchiolitis Obliterans</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Signed Informed Consent Primary lung transplant Tacrolimus maintenance therapy Bronchiolitis Obliterans Syndrome stag 1 3 : FEV1 &lt; 80 % baseline At least 3 month last usual BOS intervention Declining FEV1 last usual BOS intervention Cyclosporine maintenance therapy Bronchiolitis Obliterans Syndrome 0 : FEV1 &gt; 80 % Renal failure : Glomerular Filtration Rate &lt; 30 ml/min Chronic airway infection Clinical stability Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>Powder inhalation</keyword>
	<keyword>Side effect</keyword>
	<keyword>Nephrotoxicity</keyword>
	<keyword>Calcineurin inhibitor</keyword>
	<keyword>Bronchiolitis obliterans syndrome</keyword>
	<keyword>Forced Expiratory Volume</keyword>
</DOC>